Monday, June 24, 2013

Genetic Technologies Limited Announces The Publication Online In Breast Cancer Research & Treatment On Friday


Genetic Technologies Announces Independent Clinical Validation Study in Support of the Utilization of BREVAGen™.This independent study, which was conducted under the supervision of Prof. John Hopper and first-authored by Dr. Gillian Dite from the Centre for Molecular Epidemiology at the University of Melbourne.

www.marketwire.com/press-release/genetic-technologies-announces-independent-clinical-validation-study-support-utilization-asx-gtg-1804783.htm

No comments:

Post a Comment